Illanes-Bordomás Carlos, Landin Mariana, García-González Carlos A
AerogelsLab, I+D Farma Group (GI-1645), Department of Pharmacology, Pharmacy and Pharmaceutical Technology, iMATUS and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, E-15782 Santiago de Compostela, Spain.
Pharmaceutics. 2023 Nov 17;15(11):2639. doi: 10.3390/pharmaceutics15112639.
Polysaccharide aerogels have emerged as a highly promising technology in the field of oral drug delivery. These nanoporous, ultralight materials, derived from natural polysaccharides such as cellulose, starch, or chitin, have significant potential in colonic drug delivery due to their unique properties. The particular degradability of polysaccharide-based materials by the colonic microbiota makes them attractive to produce systems to load, protect, and release drugs in a controlled manner, with the capability to precisely target the colon. This would allow the local treatment of gastrointestinal pathologies such as colon cancer or inflammatory bowel diseases. Despite their great potential, these applications of polysaccharide aerogels have not been widely explored. This review aims to consolidate the available knowledge on the use of polysaccharides for oral drug delivery and their performance, the production methods for polysaccharide-based aerogels, the drug loading possibilities, and the capacity of these nanostructured systems to target colonic regions.
多糖气凝胶已成为口服药物递送领域一项极具前景的技术。这些由纤维素、淀粉或几丁质等天然多糖衍生而来的纳米多孔超轻材料,因其独特性能在结肠药物递送方面具有巨大潜力。基于多糖的材料可被结肠微生物群特异性降解,这使其成为制备能以可控方式装载、保护和释放药物且具备精确靶向结肠能力的系统的理想选择。这将有助于对结肠癌或炎症性肠病等胃肠道疾病进行局部治疗。尽管多糖气凝胶潜力巨大,但其这些应用尚未得到广泛探索。本综述旨在整合有关多糖用于口服药物递送及其性能、基于多糖的气凝胶生产方法、药物装载可能性以及这些纳米结构系统靶向结肠区域能力的现有知识。